» Articles » PMID: 26497425

Surface-Engineered Viral Vectors for Selective and Cell Type-Specific Gene Delivery

Overview
Specialty Biochemistry
Date 2015 Oct 27
PMID 26497425
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Recent progress in gene transfer technology enables the delivery of genes precisely to the application-relevant cell type ex vivo on cultivated primary cells or in vivo on local or systemic administration. Gene vectors based on lentiviruses or adeno-associated viruses can be engineered such that they use a cell surface marker of choice for cell entry instead of their natural receptors. Binding to the surface marker is mediated by a targeting ligand displayed on the vector particle surface, which can be a peptide, single-chain antibody, or designed ankyrin repeat protein. Examples include vectors that deliver genes to specialized endothelial cells or lymphocytes, tumor cells, or particular cells of the nervous system with potential applications in gene function studies and molecular medicine.

Citing Articles

AAV Capsid Modification and Its Influence on Viral Protein Stoichiometry and Packaging Fitness: Current Understandings and Future Direction.

Dogbey D, Barth S Mol Biotechnol. 2025; .

PMID: 39881109 DOI: 10.1007/s12033-025-01381-0.


The best of both worlds: AAV-mediated gene transfer empowered by LNP delivery of Sleeping Beauty transposase for durable transgene expression in vivo.

Sandoval-Villegas N, Ivics Z Mol Ther. 2024; 32(10):3211-3214.

PMID: 39326408 PMC: 11489527. DOI: 10.1016/j.ymthe.2024.09.002.


Strategies to improve safety profile of AAV vectors.

Suoranta T, Laham-Karam N, Yla-Herttuala S Front Mol Med. 2024; 2:1054069.

PMID: 39086961 PMC: 11285686. DOI: 10.3389/fmmed.2022.1054069.


In vivo CAR T-cell generation in nonhuman primates using lentiviral vectors displaying a multidomain fusion ligand.

Nicolai C, Parker M, Qin J, Tang W, Ulrich-Lewis J, Gottschalk R Blood. 2024; 144(9):977-987.

PMID: 38861668 PMC: 11406189. DOI: 10.1182/blood.2024024523.


Phage Display as a Medium for Target Therapy Based Drug Discovery, Review and Update.

Jahandar-Lashaki S, Farajnia S, Faraji-Barhagh A, Hosseini Z, Bakhtiyari N, Rahbarnia L Mol Biotechnol. 2024; .

PMID: 38822912 DOI: 10.1007/s12033-024-01195-6.